2013 CPT® Description
|
2014 CPT® Description
|
•0580F -Multidisciplinary care plan developed or updated (ALS)
|
|
•0581F -Patient transferred directly from anesthetizing location to critical
care unit (Peri2)
|
|
•0582F -Patient not transferred directly from anesthetizing location to
critical care unit (Peri2)
|
|
•0583F -Transfer of care checklist used (Peri2)
|
|
•0584F -Transfer of care checklist not used (Peri2)
|
|
▲1040F – DSM IV™ criteria
for major depressive disorder documented at the initial evaluation (MDD, MDD
ADOL)1
|
|
•1500F -Symptoms and
signs of distal symmetric polyneuropathy, reviewed and documented (DSP)
|
|
•1501F -Not initial
evaluation for condition (DSP)
|
|
•1502F -Patient queried
about pain and pain interferences with function using a valid and reliable
instrument (DSP)
|
|
•1503F -Patient queried
about symptoms of respiratory insufficiency (ALS)
|
|
•1504F -Patient has
respiratory insufficiency (ALS)
|
|
•1505F Patient does not
have respiratory insufficiency
|
|
•3751F –
Electrodiagnostic studies for distal symmetric polyneuropathy conducted (or
requested), documented, and reviewed within 6 months of initial evaluation
for condition (DSP)
|
|
•3752F -Electrodiagnostic
studies for distal symmetric polyneuropathy not conducted (or requested),
documented, or reviewed within 6 months of initial evaluation for condition
(DSP)
|
|
•3753F -Patient has clear
clinical symptoms and signs that are highly suggestive of neuropathy AND
cannot be attributed to another condition, AND has an obvious cause for the
neuropathy (DSP)
|
|
•3754F -Screening tests
for diabetes mellitus reviewed, requested, or ordered (DSP)
|
|
•3755F -Cognitive and behavioral impairment screening
performed (ALS)
|
|
•3756F- Patient has
pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
|
|
•3757F -Patient does not
have pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
|
|
•3758F – Patient referred
for pulmonary function testing or peak cough expiratory flow (ALS)
|
|
•3759F -Patient screened
for dysphagia, weight loss, or impaired nutrition (ALS)
|
|
•3760F -Patient exhibits
dysphagia, weight loss, or impaired nutrition (ALS)
|
|
•3761F -Patient does not
exhibit dysphagia, weight loss, or impaired nutrition (ALS)
|
|
•3762F -Patient is
dysarthric (ALS)
|
|
•3763F -Patient is not
dysarthric (ALS)
|
|
•4540F -Disease modifying
pharmacotherapy discussed (ALS)
|
|
•4541F -Patient offered
treatment for pseudobulbar affect, sialorrhea, or ALS-related symptoms (ALS)
|
|
•4550F – Options for
noninvasive respiratory support discussed with patient (ALS)
|
|
•4551F -Nutritional
support offered (ALS)
|
|
•4552F -Patient offered
referral to a speech language pathologist (ALS)”
|
|
•4553F -Patient offered
assistance in planning for end of life issues (ALS)”
|
|
•4554F -Patient received
inhalational anesthetic agent (Peri2)”
|
|
•4555F -Patient did not
receive inhalational anesthetic agent (Peri2)”
|
|
•4556F -Patient exhibits
3 or more risk factors for post-operative nausea and vomiting (Peri2)”
|
|
•4557F -Patient does not
exhibit 3 or more risk factors for post-operative nausea and vomiting
(Peri2)”
|
|
•4558F -Patient received
at least 2 prophylactic pharmacologic anti-emetic agents of different classes
preoperatively and intraoperatively (Peri2)
|
|
•4559F -At least 1 body temperature
measurement equal to or greater than 35.5 degrees Celsius (or 95.9 degrees Fahrenheit)
recorded within the 30 minutes immediately before or the 15 minutes
immediately after anesthesia end time (Peri2)
|
|
•4560F -Antesthesia
technique did not involve general or neuraxial anesthesia (Peri2)
|
|
•4561F -Patient has a
coronary artery stent (Peri2)
|
|
•4562F – Patient does not
have a coronary artery stent (Peri2)
|
|
•4563F – Patient received
aspirin within 24 hours prior to anesthesia start time (Peri2)
|
|
•9001F-Aortic aneurysm
less than 5.0 cm maximum diameter on centerline formatted CT or minor
diameter on axial formatted CT (NMA-No Measure Associated)
|
|
•9002F-Aortic aneurysm
less than 5.0 – 5.4 cm maximum diameter on centerline formatted CT or minor
diameter on axial formatted CT (NMA-No Measure Associated)
|
|
•9003F-Aortic aneurysm
less than 5.5 – 5.9 cm maximum diameter on centerline formatted CT or minor
diameter on axial formatted CT (NMA-No Measure Associated)
|
|
•9004F-Aortic aneurysm
less than 6.0 cm or greater maximum diameter on centerline formatted CT or
minor diameter on axial formatted CT (NMA-No Measure Associated)
|
|
•9005F-Asyptomatic
carotid stenosis: No history of any transient ischemic attack or stroke in
any carotid or vertebrobasilar territory (NMA – No Measure Associated)
|
|
•9006F-Symptomatic
carotid stenosis: Ipsilateral carotid territory TIA or stroke less than 120
days prior to procedure (NMA-No Measure Associated)
|
|
•9006F-Other carotid
stenosis: Ipsilateral TIA or stroke 120 days or greater prior to procedure or
any prior contralateral carotid territory or vertebrobasilar TIA or stroke
(NMA-No Measure Associated)
|
|
0078T -Endovascular repair
using prosthesis of abdominal aortic aneurysm, pseudoaneurysm for dissection,
abdominal aorta involving visceral branches, superior mesenteric, celiac
and/or renal artery(s)
|
0078T -Endovascular
repair using prosthesis of abdominal aortic aneurysm, pseudoaneurysm for
dissection, abdominal aorta involving visceral branches, superior mesenteric,
celiac and/or renal artery(s)
|
0079T -Placement of visceral
extension prosthesis for endovascular repair of endovascular repair of
abdominal aortic aneurysm involving visceral vessels, each visceral branch
|
0079T -Placement of
visceral extension prosthesis for endovascular repair of endovascular repair
of abdominal aortic aneurysm involving visceral vessels, each visceral branch
|
0080T -Endovascular repair
using prosthetics of abdominal aorta aneurysm, pseudoaneurysm/dissection
abdominal aorta involving visceral vessels, , superior mesenteric, celiac
and/or renal artery(s), radiologic supervision and interpretation
|
0080T -Endovascular
repair using prosthetics of abdominal aorta aneurysm, pseudoaneurysm/dissection
abdominal aorta involving visceral vessels, , superior mesenteric, celiac
and/or renal artery(s), radiologic supervision and interpretation
|
0081T -Placement o visceral
extension prosthesis for endovascular repair of abdominal aortic aneurysm
involving visceral vessels, each visceral branch, radiological supervision
and interpretation
|
0081T -Placement o
visceral extension prosthesis for endovascular repair of abdominal aortic
aneurysm involving visceral vessels, each visceral branch, radiological
supervision and interpretation
|
0124T -Conjunctival incision
with posterior extrascleral placement of pharmacological agent (does not
include supply of medication)
|
0124T -Conjunctival
incision with posterior extrascleral placement of pharmacological agent (does
not include supply of medication)
|
0183T -Low frequency,
non-contact, non-thermal ultrasound, including topical allicatin(s), when
performed wound assessment, and instruction(s) for ongoing care, per day
|
0183T -Low frequency,
non-contact, non-thermal ultrasound, including topical allicatin(s), when
performed wound assessment, and instruction(s) for ongoing care, per day
|
0185T -Multivariate analysis
patient specific finding with quanfiable complex problem assessment, including report
|
0185T- Multivariate
analysis patient specific finding with quanfiable complex problem assessment, including report
|
0186T – Suprachoroidal delivery
of pharmacologic agent (does not include supply of medication)
|
0186T - Suprachoroidal
delivery of pharnacologic agent (does not include supply of medication);
|
0192T – External approach
|
0192T - External approach
|
0260T -Total body system hypo,
day, neonate less than <= 28 days
|
0260T -Total body system
hypo, day, neonate less than <= 28 days
|
0261T –Selective head
hypothermia, per day, in the neonate 28 days of age or younger
|
0261T-Selective head
hypothermia, per day, in the neonate, 28 days of age or younger
|
0318T – Implantation of
catheter delivered prosthetic aortic heart valve, open thoracic approach, (e.g.,
transapical, other than transaortic);
|
0318T Implantation of
catheter-delivered prosthetic aortic heart valve, open thoracic approach,
(e.g., transapical, other than transaortic);
|
•0320T – Insertion of
subcutaneous defibrillator electrode
|
|
•0321T - Insertion of subcutaneous implantable
defibrillator pulse generator only with existing subcutaneous electrode
|
|
•0322T – Removal of
subcutaneous implantable defibrillator pulse generator only
|
|
•0323T – Removal of
subcutaneous implantable defibrillator pulse generator with replacement of
subcutaneous implantable defibrillator pulse generator only
|
|
•0324T – Removal of
subcutaneous defibrillator electrode
|
|
•0325T – Repositioning of
subcutaneous implantable defibrillator electrode and/or pulse generator
|
|
•0326T -
Electrophysiologic evaluation of subcutaneous implantable defibrillator
(includes defibrillation threshold evaluation, induction of arrhythmia evaluation
of sensing for arrhythmia termination, and programming or reprogramming of
sensing or therapeutic parameters
|
|
•0327T – Interrogation
device evaluation (in person) with analysis, review and report, includes
connection, recording and disconnection per patient encounter, implantable
subcutaneous lead defibrillator system
|
|
•0328T – Programming
device evaluation (in person) with iterative adjustment of the implantable
device to test the function of the device and select optimal permanent
programmed values with analysis, implantable subcutaneous lead defibrillator
system
|
|
•0329T - Monitoring of
intraocular pressure for 24 hours or longer, unilateral or bilateral, with
interpretation and report
|
|
•0330T – Tear film
imaging, unilateral or bilateral, with interpretation and report
|
|
•0331T – Myocardial
sympathetic innervation imaging, planar qualitative and quantitative
assessment;
|
|
•0332T – with tomographic
SPECT
|
|
•0333T – Visual evoked
potential, screening of visual acuity, automated
|
|
•0334T – Sacroiliac joint
stabilization for arthrodesis, percutaneous or minimally invasive (indirect
visualization), includes obtaining and applying autograft or allograft
(structural or morselized), when performed, includes image guidance when
performed (eg, CT or fluoroscopic)
|
|
•⦿0335T - Extra-osseous subtalar joint implant for
talotarsal stabilization
|
|
•0336T - Laparoscopy,
surgical, ablation of uterine (fibroid(s), including intraoperative
ultrasound guidance and monitoring, radiofrequency
|
|
•0337T - Endothelial
function assessment, using peripheral vascular response to reactive
hyperemia, non-invasive (e.g., brachial artery ultrasound, peripheral artery
tonometry), unilateral or bilateral
|
|
•0338T - Transcatheter
renal sympathetic denervation, percutaneous approach including arterial
puncture, selective catheter placement(s) renal artery(ies), fluoroscopy,
contrast Injection (s), intraprocedural roadmapping and and radiological
supervision and interpretation, including pressure gradient measurements,
flush aortogram and diagnostic renal angiography when performed; unilateral
|
|
•0339T - bilateral
|
Friday, 11 April 2014
CPT Deleted and New Codes in 2014 for Cardiology
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment